Cargando…
Prediction of Prognosis and Chemotherapeutic Sensitivity Based on Cuproptosis-Associated lncRNAs in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma
Cervical cancer is the fourth most common cancer. The 5-year survival rate for metastatic cervical cancer is less than 10%. The survival time of patients with recurrent cervical cancer is approximately 13–17 months. Cuproptosis is a novel type of cell death related to mitochondrial respiration. Accu...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10379127/ https://www.ncbi.nlm.nih.gov/pubmed/37510286 http://dx.doi.org/10.3390/genes14071381 |
_version_ | 1785079936942342144 |
---|---|
author | Zhou, Jianghong Xu, Lili Zhou, Hong Wang, Jingjin Xing, Xiaoliang |
author_facet | Zhou, Jianghong Xu, Lili Zhou, Hong Wang, Jingjin Xing, Xiaoliang |
author_sort | Zhou, Jianghong |
collection | PubMed |
description | Cervical cancer is the fourth most common cancer. The 5-year survival rate for metastatic cervical cancer is less than 10%. The survival time of patients with recurrent cervical cancer is approximately 13–17 months. Cuproptosis is a novel type of cell death related to mitochondrial respiration. Accumulative studies showed that long non-coding RNAs (lncRNAs) regulated cervical cancer progression. Compressive bioinformatic analysis showed that nine cuproptosis-related lncRNAs (CRLs), including C002128.2, AC002563.1, AC009237.14, AC048337.1, AC145423.1, AL117336.1, AP001542.3, ATP2A1-AS1, and LINC00426, were independently correlated with the overall survival (OS) of cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) patients. The time-dependent area under curve value reached 0.716 at 1 year, 0.718 at 3 years, and 0.719 at 5 years. Notably, CESC patients in the low-risk group had increased immune cell infiltration and expression of several immune checkpoints, which indicated that they may benefit more from immune checkpoint blockade therapy. In addition, we also used the model for drug sensitivity analysis. Several drug sensitivities were more sensitive in high-risk patients and showed significant correlations with the risk models, such as Bortezomib_1191, Luminespib_1559, and Rapamycin_1084, suggesting that these drugs may be candidate clinical drugs for patients with a high risk of CESC. In summary, this study further explored the mechanism of CRLs in CESC and provided a more optimized prognostic model and some insights into chemotherapy of CESC. |
format | Online Article Text |
id | pubmed-10379127 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103791272023-07-29 Prediction of Prognosis and Chemotherapeutic Sensitivity Based on Cuproptosis-Associated lncRNAs in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma Zhou, Jianghong Xu, Lili Zhou, Hong Wang, Jingjin Xing, Xiaoliang Genes (Basel) Article Cervical cancer is the fourth most common cancer. The 5-year survival rate for metastatic cervical cancer is less than 10%. The survival time of patients with recurrent cervical cancer is approximately 13–17 months. Cuproptosis is a novel type of cell death related to mitochondrial respiration. Accumulative studies showed that long non-coding RNAs (lncRNAs) regulated cervical cancer progression. Compressive bioinformatic analysis showed that nine cuproptosis-related lncRNAs (CRLs), including C002128.2, AC002563.1, AC009237.14, AC048337.1, AC145423.1, AL117336.1, AP001542.3, ATP2A1-AS1, and LINC00426, were independently correlated with the overall survival (OS) of cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) patients. The time-dependent area under curve value reached 0.716 at 1 year, 0.718 at 3 years, and 0.719 at 5 years. Notably, CESC patients in the low-risk group had increased immune cell infiltration and expression of several immune checkpoints, which indicated that they may benefit more from immune checkpoint blockade therapy. In addition, we also used the model for drug sensitivity analysis. Several drug sensitivities were more sensitive in high-risk patients and showed significant correlations with the risk models, such as Bortezomib_1191, Luminespib_1559, and Rapamycin_1084, suggesting that these drugs may be candidate clinical drugs for patients with a high risk of CESC. In summary, this study further explored the mechanism of CRLs in CESC and provided a more optimized prognostic model and some insights into chemotherapy of CESC. MDPI 2023-06-30 /pmc/articles/PMC10379127/ /pubmed/37510286 http://dx.doi.org/10.3390/genes14071381 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Zhou, Jianghong Xu, Lili Zhou, Hong Wang, Jingjin Xing, Xiaoliang Prediction of Prognosis and Chemotherapeutic Sensitivity Based on Cuproptosis-Associated lncRNAs in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma |
title | Prediction of Prognosis and Chemotherapeutic Sensitivity Based on Cuproptosis-Associated lncRNAs in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma |
title_full | Prediction of Prognosis and Chemotherapeutic Sensitivity Based on Cuproptosis-Associated lncRNAs in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma |
title_fullStr | Prediction of Prognosis and Chemotherapeutic Sensitivity Based on Cuproptosis-Associated lncRNAs in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma |
title_full_unstemmed | Prediction of Prognosis and Chemotherapeutic Sensitivity Based on Cuproptosis-Associated lncRNAs in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma |
title_short | Prediction of Prognosis and Chemotherapeutic Sensitivity Based on Cuproptosis-Associated lncRNAs in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma |
title_sort | prediction of prognosis and chemotherapeutic sensitivity based on cuproptosis-associated lncrnas in cervical squamous cell carcinoma and endocervical adenocarcinoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10379127/ https://www.ncbi.nlm.nih.gov/pubmed/37510286 http://dx.doi.org/10.3390/genes14071381 |
work_keys_str_mv | AT zhoujianghong predictionofprognosisandchemotherapeuticsensitivitybasedoncuproptosisassociatedlncrnasincervicalsquamouscellcarcinomaandendocervicaladenocarcinoma AT xulili predictionofprognosisandchemotherapeuticsensitivitybasedoncuproptosisassociatedlncrnasincervicalsquamouscellcarcinomaandendocervicaladenocarcinoma AT zhouhong predictionofprognosisandchemotherapeuticsensitivitybasedoncuproptosisassociatedlncrnasincervicalsquamouscellcarcinomaandendocervicaladenocarcinoma AT wangjingjin predictionofprognosisandchemotherapeuticsensitivitybasedoncuproptosisassociatedlncrnasincervicalsquamouscellcarcinomaandendocervicaladenocarcinoma AT xingxiaoliang predictionofprognosisandchemotherapeuticsensitivitybasedoncuproptosisassociatedlncrnasincervicalsquamouscellcarcinomaandendocervicaladenocarcinoma |